Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Dec 2021 for Soliton, Inc., €184.4M.
Insider track record
Disclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Remeditex Ventures LLC: trading record in brief
Remeditex Ventures LLC discloses dealings in 4 companies, chiefly Bellicum Pharmaceuticals, Inc, Soliton, Inc. and Yarrow Bioscience, Inc. In total, 13 filings cover trades dated from 23 December 2014 to 16 December 2021.
Purchases make up the whole of the open-market record (4 purchases, €2.3M). The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 17 December 2021, reports a transaction of €184.4M in Soliton, Inc. The last insider purchase was made public on 1 July 2020, 2,305 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Remeditex Ventures LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
9,214,277 shares@ US$22.60100.0% of flowCommon StockSEC:0001548187-21-000080:0
1 of 1 declaration
